Skip to main content
Membership NewsMembership News Archive

Commercial partner needed for novel sudden cardiac death diagnostic test

By March 6, 2024No Comments

Dr Angeliki Asimaki, Senior Lecturer in Sudden Death based at St George’s, University of London, is seeking a commercial partner or support organisation for her test to diagnose risk of sudden cardiac death.

Dr Asimaki studies a disease called arrhythmogenic cardiomyopathy, one of the major causes of sudden death in all populations of the world. Currently, there is no gold standard test for the diagnosis of this deadly disease, which in many cases remains ambivalent.

She spent a long spell at Harvard University in Boston, USA, where she developed a test allowing for the study the distribution of key proteins in cheek swabs by immunocytochemistry and microscopy and hence establish a diagnosis.

This test is now being used in paediatric patients at the Great Ormond Street Hospital in a project funded by the British Heart Foundation.

She aims to apply for an Advanced Fellowship to the NIHR to further develop the use of this test in a much higher number of patients. Part of her fellowship application includes liaising with a commercial partner.

At this stage what is required is a letter of support from an external service stating that if the project is successful, they would consider being involved in the commercialisation of the product.

If you are interested in this endeavour, please contact Dr Asimaki.

Publications related to the test’s discovery can be accessed on request.

Ben Kemp